RA Capital Management
Founded:
2001
Investments:
288
Exits:
140
RA Capital Management is an investment advisor specializing in the life-sciences and drug development sectors.
Portfolio companies:
Somatus,Exo,Element Biosciences,Mineralys Therapeutics,Sionna Therapeutics,GentiBio,Boundless Bio,Artiva Biotherapeutics,Frontier Medicines,Ceribell,Be Biopharma,Scribe Therapeutics,Tasso,Antios Therapeutics,Acrivon Therapeutics,Cedilla Therapeutics,Curie Therapeutics,Locanabio,Plexium,Obsidian Therapeutics,Electra Therapeutics,ViaCyte,Synthekine,Asher Bio,Jnana Therapeutics,DTx Pharma
Health & Wellness
BioTech
Artificial Intelligence & Machine Learning (AI/ML)
Boston
Pre-Seed
Seed
Series A
Series B
Series C
Series D
United States